National Vision Appoints Susan O'Farrell to Audit Committee

National Vision Holdings, Inc. (NASDAQ: EYE) has announced the appointment of Susan O'Farrell to its board of directors and as a member of its audit committee. Ms. O'Farrell is an accomplished financial expert with over 35 years of executive and senior leadership experience, bringing additional financial, operational, and supply chain expertise to the board.

Randy Peeler, Chairman of National Vision's board of directors, expressed his enthusiasm about Susan O'Farrell's appointment, stating, "Susan is an exemplary addition to our board, and we are thrilled to welcome her. Her expertise will bring new perspective, both deepening the strength and expanding the view of the board."

In response to her appointment, Ms. O'Farrell shared her excitement, especially amid the ever-changing landscape of both the healthcare and retail industries. She expressed her passion for providing high-quality care at an affordable cost and looks forward to working together with leadership and her fellow board members to advance the company's mission.

Reade Fahs, CEO at National Vision, also expressed his appreciation for O'Farrell's addition to the board, stating, "Susan brings a wealth of both retail and multi-industry knowledge to National Vision. We feel incredibly fortunate to add her strengths to our board."

National Vision Holdings, Inc. (NASDAQ: EYE) is the nation's second largest optical retailer, providing quality, affordable eye care and eyewear. The company operates over 1,400 stores in 44 states and Puerto Rico, with a mission to make quality eye care and eyewear more affordable and accessible.

Following this announcement, the company's shares have moved 2.7%, and are now trading at a price of $19.94.

The company's full 8-K submission is available here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.